Uzbekistan: MSF Successfully Concludes Nukus TB Project
September 23, 2025Nukus/ Amsterdam, 22 September 2025 – Médecins Sans Frontières (MSF), the Ministry of Health of Uzbekistan (MoH) and the Ministry of Health of Karakalpakstan today marked the successful conclusion of their long-running collaboration on the Karakalpakstan Tuberculosis Programme. The closing...
Read more
Early Results of First Trial Conducted Exclusively in People with Pre-Extensively Drug-Resistant Tuberculosis Show Promise
August 1, 2025Paris/Boston, 13 November 2024 - The endTB consortium has completed endTB-Q, the first Phase 3 randomized controlled trial to exclusively enroll people suffering from pre-extensively drug-resistant tuberculosis (pre-XDR-TB), a very hard-to-treat form of tuberculosis (TB). The trial, conducted by the endTB...
Read more
From innovation to action: MSF shares 25 years of lessons learned in tackling Drug-Resistant TB
January 22, 2025January 22, 2025, New Delhi: Médecins Sans Frontières (MSF)/Doctors Without Borders, in partnership with the National TB Elimination Program (NTEP) and the Brihanmumbai Municipal Corporation (BMC), hosted a panel discussion today to mark the culmination of 25 years of continuous...
Read more
After 18 years, MSF hands over its Drug-Resistant Tuberculosis (DR-TB) Project to the National TB Elimination Program in Mumbai
September 27, 202427 Sept 2024, Mumbai: Médecins Sans Frontières (MSF)/Doctors Without Borders today announced the planned closure of its Mumbai-based Drug-Resistant Tuberculosis (DR-TB) project by the end of 2024. This significant initiative has been providing comprehensive care to patients with complex cases...
Read more
India: Mumbai TB Symposium Focuses on Advancing TB Treatment and Collaboration
June 11, 202410 June 2024, Mumbai: A pivotal symposium organised today by Médecins Sans Frontières (MSF)/Doctors Without Borders brought together a diverse coalition of experts and stakeholders to forge actionable strategies against Drug-Resistant Tuberculosis (DRTB). This crucial gathering aimed to highlight the...
Read more
India: How Deepak Shegar overcame DR-TB to reclaim his dreams
June 10, 2024Mumbai, India- "When I recover, I want to play cricket," says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and...
Read more
Deepak Shegar: Battling DR-TB with resilience and dreams
June 10, 2024"When I recover, I want to play cricket," says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire...
Read more
Urgent call for Europe to improve treatment access for tuberculosis: Many TB medicines and formulations accessible in lower- and middle-income countries remain unaffordable or unavailable in Europe
June 7, 2024Berlin, 6 June 2024: As the World Health Organization (WHO) concluded a meeting with European health officials and civil society to improve access to tuberculosis (TB) medicines in the European Union (EU)/European Economic Area (EEA), Médecins Sans Frontières/Doctors Without Borders...
Read more
MSF reveals cost of its landmark TB clinical trial: €34 million
April 26, 2024MSF urges public and non-profit actors to publish clinical trial costs to improve access to medical products for all. Geneva, 25 April 2024 - At the 5th WHO Pharmaceutical Pricing and Reimbursement Policies conference today, Doctors Without Borders/Médecins Sans Frontières...
Read more
Myanmar: I have defeated TB and I wish the same for other patients
April 8, 2024Multi-drug resistant tuberculosis is one of the most complex types of tuberculosis you can get. As opposed to drug-sensitive, which responds well to the medication, multi-drug resistant tuberculosis, by its very name, is resistant to some of the drugs used...
Read more
Namrata’s journey: triumph over drug-resistant Tuberculosis
March 24, 2024Mumbai, India- Namrata's story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even formidable conditions like drug-resistant tuberculosis (DR-TB)...
Read more
Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis
March 24, 2024Namrata's story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even conditions like drug-resistant tuberculosis (DR-TB) can be overcome....
Read more
